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Abstract
Coral reefs are in severe decline. Infections by the human pathogen Serratia marcescens have contributed to precipitous
losses in the common Caribbean elkhorn coral, Acropora palmata, culminating in its listing under the United States
Endangered Species Act. During a 2003 outbreak of this coral disease, called acroporid serratiosis (APS), a unique strain of
the pathogen, Serratia marcescens strain PDR60, was identified from diseased A. palmata, human wastewater, the non-host
coral Siderastrea siderea and the corallivorous snail Coralliophila abbreviata. In order to examine humans as a source and
other marine invertebrates as vectors and/or reservoirs of the APS pathogen, challenge experiments were conducted with A.
palmata maintained in closed aquaria to determine infectivity of strain PDR60 from reef and wastewater sources. Strain
PDR60 from wastewater and diseased A. palmata caused disease signs in elkhorn coral in as little as four and five days,
respectively, demonstrating that wastewater is a definitive source of APS and identifying human strain PDR60 as a coral
pathogen through fulfillment of Koch’s postulates. A. palmata inoculated with strain PDR60 from C. abbreviata showed
limited virulence, with one of three inoculated fragments developing APS signs within 13 days. Strain PDR60 from non-host
coral S. siderea showed a delayed pathogenic effect, with disease signs developing within an average of 20 days. These
results suggest that C. abbreviata and non-host corals may function as reservoirs or vectors of the APS pathogen. Our results
provide the first example of a marine ‘‘reverse zoonosis’’ involving the transmission of a human pathogen (S. marcescens)t o
a marine invertebrate (A. palmata). These findings underscore the interaction between public health practices and
environmental health indices such as coral reef survival.
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Introduction
Once the most common coral in the Caribbean, elkhorn coral
Acropora palmata was listed for protection under the United States
Endangered Species Act in 2006 [1], largely due to a disease
unique to this coral species (Fig. 1). This disease, termed white pox
or acroporid serratiosis (APS), is caused by the bacterium Serratia
marcescens [2]. S. marcescens is an opportunistic human pathogen,
causing respiratory, wound and urinary tract infections, meningitis
and pneumonia [3–10]. Human diseases caused by this bacterium
have been associated with waterborne infections in tropical
freshwaters [11], but are most often associated with nosocomial
infections of neonates and immuno-compromised patients [12].
During a 2003 outbreak, a unique strain of S. marcescens, strain
PDR60, was identified from both diseased A. palmata and
untreated human sewage, suggesting a causal link between
wastewater and APS [13]. In addition, strain PDR60 was isolated
from potential vectors and reservoirs including the non-host corals
Siderastrea siderea and Solenastrea bournoni and the coral predatory
snail Coralliophila abbreviata [13].
Koch’s postulates, the preferred method for proving disease
causation in humans and wildlife, require inoculation of a pure
culture of a suspected pathogen isolated from a diseased host onto
an apparently healthy host followed by development of disease
signs and reisolation of the pathogen. Koch’s postulates have
proven difficult to fulfill for a number of coral diseases due in part
to difficulty isolating and identifying potential pathogens and
growing these organisms in pure culture. To date, the postulates
have been satisfied for only five coral diseases, including APS with
strain PDL100 isolated from a 1999 outbreak [2,14]. Unlike strain
PDR60, isolated from host and non-host corals and snails, strain
PDL100 has been identified only from diseased Acropora palmata
[13]. Here we hypothesize that strain PDR60 isolated from two
distinct environments, one terrestrial (human wastewater) and one
marine (APS-affected A. palmata, apparently healthy Siderastrea
siderea and Coralliophila abbreviata) causes APS in A. palmata.T o
examine this hypothesis we conducted challenge experiments by
inoculating eight isolates of Serratia marcescens representing three
strains onto A. palmata fragments maintained in closed seawater
aquaria. Our results confirm strain PDR60 as a coral pathogen
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consistent with the hypothesis that non-host corals and predatory
snails may function as interepizootic reservoirs or vectors of the
APS pathogen. Furthermore, we show that S. marcescens isolated
from human wastewater causes APS in as little as four days,
unequivocally verifying humans as a source of a marine inverte-
brate disease.
Materials and Methods
Challenge Experiment Design
Experiments were conducted in June 2009 at the Mote Tropical
Research Laboratory (MTRL), Summerland Key, FL. Eleven
aquaria (20 L) were placed in a wet-table raceway with flowing
20 mm filtered groundwater and filled with 10 mm filtered
seawater. A pump was placed in each aquarium, approximately
1 cm below the water surface, to maintain aeration. The raceway
was covered with a plastic tarp and this shading plus water
circulating around aquaria maintained aquaria temperatures at
28uC. Aquaria containing seawater acclimated for 24 hours before
corals were added.
Small Acropora palmata fragments (25 cm
2) were collected from 19
apparently healthy colonies at Western Sambo Reef, FL. Prior to
fragment collection, the surface mucopolysaccharide layer (SML)
was removed from each of the 19 coral colonies using sterile needle-
less 20 cm
3 syringes and placed in a cooler on ice. Coral fragments
were placed in 1 gallon zip-lock plastic bags containing seawater
and stored in a cooler without ice. SML and coral samples were
transported to the MTRL. Within three hours of collection, SML
samples were spread plated (100 ml) on MacConkey Sorbitol agar
(Becton Dickinson, Franklin Lakes, NJ, USA) with colistin (200 U
ml-1; MP Biomedicals, Aurora, OH, USA) (MCSA) [15].
Inoculated MCSA plates were incubated overnight at 37uC.
The number of coral fragments collected per coral colony ranged
from one to four (Table 1). Within three hours of collection, these
fragments were distributed into aquaria, three fragments per
aquarium, with the goal of limiting replication of fragments from
any one colony in a single aquarium. For colonies from which more
than one fragment was collected, this distribution of fragments
allowed for genotype comparisons across treatments (Table 1).
Clonal replication within an aquarium was measured in aquariums
4 and 10 (Table 2) to determine genotype response to a single
Figure 1. Time series of white pox affected Acropora palmata at Looe Key Reef in the Florida Keys and average time to tissue loss in
the challenge experiments. A. Images of white pox affected A. palmata at Looe Key, from June 2008, to June 2009, to July 2009 (left to right),
show colony growth and partial mortality. Scales bars are 3 cm on a side or 3 cm in diameter. (Photographs by JW Porter and MK Meyers) B. Average
time (days) to development of disease signs on A. palmata inoculated with Serratia marcescens. Days to tissue loss was averaged for the three A.
palmata fragments used in each treatment and each control. The original inoculum was recovered for all seven of the presented S. marcescens
inocula, including five isolates of strain PDR60 collected from acroporid serratiosis (APS)-affected A. palmata (isolates 1, 2), non-host coral Siderastrea
siderea (isolate 4), corallivorous snail Coralliophila abbreviata (isolate 5), and untreated wastewater (isolate 6). Two additional inocula included S.
marcescens strain PDL100 (isolate 7), previously confirmed as an APS pathogen through fulfillment of Koch’s Postulates (2) and S. marcescens strain
WWI31 from untreated wastewater (isolate 8). The vehicle control exhibited tissue loss beginning at day 15. The E. coli-plus-vehicle control and the
isolate 3-plus-vehicle treatment did not exhibit tissue loss and remained apparently healthy for the duration of the 26 day study. Virulent strains
(isolates 1, 2, 5, 6, 8) caused tissue loss within 14 days of inoculation and attenuated strains (isolates 4, 7) caused tissue loss after day 14.
doi:10.1371/journal.pone.0023468.g001
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48 hours prior to commencement of inoculation experiments.
Challenge Experiment Inoculations
Test isolates used in the challenge experiments were collected
between June 2002 and August 2006 from off-shore coral reefs and
wastewater in the Florida Keys (Table 3). These Serratia marcescens
isolates were cultured and identified from environmental samples
by Sutherland et al. [13] using a three-step method: culture on
MCSA followed by culture on DNase with Toluidine Blue agar
(DTC; Becton Dickinson) amended with cephalothin (0.1 mg
ml
21; ICN Biomedicals, Aurora, OH, USA) [16] followed by
Serratia-specific PCR with primers Smar 16SV (GGGAGCT-
TGCTCACTGGGTG) and Smar 16SWR (GCGAGTAACGT-
CAGTTGATGAGCGTATTA) (Sigma-Genosys, Woodlands,
TX) [17]. The efficiency of these methods for the isolation of S.
marcescens was confirmed with sequencing of 16S rDNA PCR
amplicons [13]. Genotypic fingerprinting (by endonuclease
restriction) of environmental isolates of S. marcescens was conducted
with pulsed-field gel electrophoresis (PFGE), based on the
protocols of Miranda et al. [8] and Shi et al. [9], in order to
determine relatedness between isolates and to assess genetic
similarity among and between strains [13]. PFGE is widely
recognized as an outstanding method for molecular strain typing
of S. marcescens and is commonly employed to source track clinical
outbreaks caused by this bacterium [8,9,18–25].
Six of the test isolates used in the challenge experiments were a
single PFGE-identified strain, Serratia marcescens PDR60, collected
from APS-affected Acropora palmata at Rock Key reef in the lower
Keys (isolate 1) and Grecian Rocks reef in the upper Keys (isolates
2, 3), the apparently healthy non-host coral Siderastrea siderea (isolate
4) at Long Key, the corallivorous snail Coralliophila abbreviata (isolate
5) at Sand Key reef, and from untreated wastewater (isolate 6)
from the Key West wastewater treatment facility (Table 3) [13].
The known coral pathogenic strain, S. marcescens PDL100 (isolate 7)
[2] and one additional isolate, representing a different S. marcescens
strain, WWI31, from untreated wastewater (isolate 8) [13] were
also tested (Table 3). Controls included Escherichia coli (ATCC
15597), vehicle (sterile CaCO3 sediment), and seawater. One
aquarium containing three coral fragments was used for each
treatment and each control (Table 2). Due to the threatened status
of A. palmata, the scope of our study was limited to eight treatments
and three controls, each in a single dose, by the small size and low
number of coral fragments that were permitted for collection.
Bacterial cultures of test isolates were prepared by combining
15 ml trypticase soy (TS) broth (Becton Dickinson, Sparks, MD,
USA) and 15 g sterile sieved (1 mm internal diameter) CaCO3
sediment in sterile 50 ml tubes and inoculating eachbroth-sediment
mixture with a test isolate. Vehicle control was prepared as above,
butwithoutbacterialinoculum.Inoculated mixtureswereincubated
overnight (25uC) with horizontal shaking and grown to 10
7 colony
forming units ml
21. Overnight cultures were centrifuged (5 min,
10006 g) and supernatant discarded. Sterile artificial seawater
(ASW, 15 ml) was added to the pellet containing cells and sediment
and mixed by inversion. Inoculations were performed by depositing
0.85 g of each bacterial absorbed sediment mixture directly onto
triplicate fragments in a single aquarium. Fragments that did not
develop disease signs within seven days (Table 2) were inoculated
again with fresh bacterial absorbed sediment. Fragments were
photographed immediately before and after inoculation.
Data Collection
The number of days to tissue loss for each coral fragment was
calculated from the first experimental inoculation (Table 2). When
tissue loss was observed, the fragment was photographed and SML
(containing necrotic coral tissue) was collected from the lesion
margin using a sterile needle-less 20 cm
3 syringe. SML was
transferred to a sterile 15 ml plastic tube and centrifuged (5 min,
10006g) and supernatant discarded. The pellet was resuspended in
ASW (500 ml) and spread plated (100 ml) in triplicate on MCSA.
Inoculated MCSA plates were incubated overnight at 37uC. MCSA
positive bacterial colonies, appearing pink to red on MCSA
(characteristic of Serratia marcescens), were picked and plated onto
DTC. Inoculated DTC plates were incubated overnight at 41uC.
Presumptive S. marcescens, determined by a DNase-positive reaction
(appearance of a red halo on DTC), were streaked onto non-
Table 1. Acropora palmata colonies used in the challenge
experiments.
Colony
Number of
Fragments Tissue Loss
No Tissue
Loss
1 2 F1 Isolate 2 A. palmata
F1 Isolate 8 wastewater
2 1 F3 Isolate 4 S. siderea
3 1 F1 Isolate 5 C.
abbreviata
4 3 F3 Isolate 2 A. palmata
F1 Isolate 7 PDL100
F3 Isolate 7 PDL100
5 3 F2 Isolate 4 S. siderea
F2 Isolate 6 wastewater
F3 seawater
control
6 2 F3 vehicle control F3 Isolate 3 A.
palmata
7 4 F1 Isolate 1 A. palmata
F2 Isolate 1 A. palmata
F2 Isolate 2 A. palmata
F1 Isolate 4 S. siderea
8 1 F1 seawater
control
9 1 F1 vehicle control
10 2 F3 Isolate 5 C. abbreviata
F2 Isolate 7 PDL100
11 2 F3 Isolate 8 wastewater F2 E. coli
control
12 1 F1 Isolate 6 wastewater
13 3 F1 Isolate 3 A.
palmata F2
Isolate
5 C. abbreviata
F3 E. coli
control
14 2 F3 Isolate 1 A. palmata
F2 Isolate 8 wastewater
15 1 F2 vehicle control
16 1 F1 E. coli
control
17 1 F2 Isolate 3 A.
palmata
18 1 F3 Isolate 6 wastewater
19 1 F2 seawater
control
Number of fragments per A. palmata colony, the challenge for each fragment
(control or inoculation with a Serratia marcescens test isolate), and the result of
each challenge (tissue loss or no tissue loss) are included. Three coral fragments
(F1, F2, F3) were used for each challenge.
doi:10.1371/journal.pone.0023468.t001
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of pure colonies. Experiments were monitored several times daily.
Partialwaterchanges wereconductedatleastoncedaily andsalinity
was maintained at 35 (measured by refractometry). After 26 days
experiments were concluded. All fragments remaining alive were
apparently healthy. Each fragment was photographed and then
SML was collected and processed as described above. At the
conclusion of experiments, or after development of disease signs and
examination of SML, each Acropora palmata fragment was fixed with
Z-Fix concentrate (ANATECH, LTD, Battle Creek, MI, USA)
diluted 1:4 with ASW and stored for future study.
Strain Typing of APS Pathogens
Isolates recovered from APS-affected Acropora palmata fragments
in inoculation experiments and identified as presumptive Serratia
marcescens by differential growth on MCSA and DTC were assayed
with Serratia-specific PCR as described above and in Sutherland
et al. [13] to confirm the identity of isolates as S. marcescens. PCR-
confirmed S. marcescens were assayed with PFGE as described in
Sutherland et al. [13]. Band patterns were used to determine
relatedness between isolates in order to confirm that bacteria
collected from APS lesions produced during inoculation experi-
ments were the same strain of bacterium inoculated in each
inoculation experiment, thereby fulfilling Koch’s postulates.
Results
Serratia marcescens were not identified from SML of any Acropora
palmata fragments prior to use in challenge experiments or from
any apparently healthy fragments remaining alive at the end of the
Table 2. Treatments and controls used in the challenge experiments.
Aquarium
Coral
Fragment
Coral
Colony Challenge
No. Days To
Tissue Loss
1 F1 8 Seawater Control No Tissue Loss
F2 19 No Tissue Loss
F3 5 No Tissue Loss
2F 1 1 6 E.coli Control No Tissue Loss
F2 11 No Tissue Loss
F3 13 No Tissue Loss
3 F1 9 Vehicle Control 17
F2 15 15
F3 6 17
4 F1 7 Isolate 1 Acropora palmata 10
F2 7 10
F3 14 9
5 F1 1 Isolate 2 A. palmata 7
F2 7 5
F3 4 7
6 F1 13 Isolate 3 A. palmata No Tissue Loss
F2 17 No Tissue Loss
F3 6 No Tissue Loss
7 F1 7 Isolate 4 Siderastrea siderea 19
F2 5 23
F3 2 19
8 F1 3 Isolate 5 Coralliophila abbreviata No Tissue Loss
F2 13 No Tissue Loss
F3 10 13
9 F1 12 Isolate 6 Wastewater 4
F2 5 4
F3 18 4
10 F1 4 Isolate 7 PDL100 A. palmata 19
F2 10 18
F3 4 19
11 F1 1 Isolate 8 Wastewater 11
F2 14 12
F3 11 12
A total of eleven challenge experiments were conducted each within a single aquarium and each with three Acropora palmata coral fragments (F1, F2, F3). Coral colony
of origin and number of days to tissue loss is included for each coral fragment. Treatments and controls for which there was no tissue loss are also noted.
doi:10.1371/journal.pone.0023468.t002
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water changes in aquaria, and deionized water used to adjust
salinity were all negative for S. marcescens. A. palmata fragments in
the E. coli-plus-vehicle control, the seawater-alone control, and the
isolate 3-plus-vehicle treatment aquaria remained apparently
healthy and were maintained for the duration of the 26 day
study. In the vehicle control aquarium, coral tissue loss was noted
by day 15 (Table 2). Therefore, test inocula were considered
virulent if disease signs occurred prior to day 15, or within 14 days
of the first inoculation, and attenuated if disease signs developed
after 14 days.
When disease occurred, the process began with the distinct
smell of Acropora palmata mucus followed by decreased water clarity,
presumably due to the release of mucus by the coral into the water.
Seawater in the affected aquaria was changed every two to five
hours once these signs developed. Mucus release was followed by a
tissue bleb adjacent the region of inoculation. Finally, the tissue
lifted off the skeleton and was sloughed in stringy fragments. This
process of disease progression, once begun, was completed within
24 hours.
Koch’s postulates were satisfied for Serratia marcescens strain
PDR60 from APS-affected corals (isolates 1, 2). Acropora palmata
fragments also developed APS signs when inoculated with two S.
marcescens strains from wastewater [strain PDR60 (isolate 6) and
strain WWI31 (isolate 8)] and with strain PDR60 from healthy non-
host corals (isolate 4) and snails (isolate 5); however, individual
strains showed varying degrees of pathogenic effect. Strain PDR60
from APS-affected corals and wastewater (isolates 1, 2, 6) caused
disease signs within four to ten days (Table 2, Fig. 1). Strain WWI31
(isolate 8) from wastewater caused disease signs within 12 days.
Isolate 4 (strain PDR60 from Siderastrea siderea) and strain PDL100
(isolate 7), were attenuated, and only caused disease signs at 23 and
19 days, respectively (Table 2, Fig. 1). PFGE analyses demonstrated
that the original inocula were recovered from all APS lesions.
Discussion
Serratia marcescens strain PDR60 isolated from wastewater and
diseased Acropora palmata caused APS in as little as four days,
confirming humans as a source of this disease. Although the scope
of this study was limited to three replicate A. palmata fragments in a
single aquarium for each treatment and each control, our results
with strain PDR60 from wastewater, predatory snails, and non-
host corals contribute to the understanding of the mechanisms of
transmission of APS and of the factors that drive the emergence
and maintenance of this marine epizootic.
Acropora palmata inoculated with strain PDR60 from the non-host
coral Siderastrea siderea (isolate 4) and strain PDL100 from APS-
affected host corals (isolate 7) showed an attenuated pathogenic
affect (Fig. 1). These two isolates caused APS signs after the
fragments in the vehicle control showed tissue loss. All other
treatments that exhibited tissue loss, did so by day 13, two days
before the vehicle control (Table 2). For this reason, results for
isolates 4 and 7, may indicate that stressors other than Serratia
marcescens infection contributed to tissue loss; however, the
maintenance of the E. coli-plus-vehicle control and the isolate 3-
plus-vehicle treatment for the duration of the 26 day study lends
support to the pathogenic effects of isolate 4 and isolate 7. Results
with isolate 4 indicate that S. siderea, and possibly other non-host
corals (e.g., Solenastrea bournoni) [13], may serve as a reservoir for the
acroporid pathogen in the reef environment. Previous work
suggests that PDL100 is poorly adapted for survival in the marine
environment, persisting in seawater for only 15 h [26], but survival
and proliferation of this strain is enhanced when it is grown in A.
palmata SML and S. siderea SML [26,27]. Our results indicate that
PDL100 survived for at least 11 days in association with A. palmata;
PDL100 was recovered from an APS lesion on day 19 of the
experiment (Table 2), 11 days after the second experimental
inoculation. S. marcescens resident in non-host SML may be
transmitted to neighboring A. palmata by sloughing of SML or
movement by Coralliophila abbreviata vectors [13].
Coralliophila abbreviata preys preferentially on Acropora palmata [28]
and has been implicated in the transmission of an unknown disease
of Acropora cervicornis [29]. Strain PDR60 from C. abbreviata (isolate
5) was virulent, but only in one of three fragments (Table 2).
Colony 13, a colony for which genotype comparisons across
treatments were conducted, did not develop APS signs when
inoculated with isolate 5 (Table 2) or with any other treatment
(Table 1). The limited virulence of isolate 5 may be due to the
apparent APS resistance of colony 13 or to the specific origin of
this isolate, collected in 2006 at Sand Key reef when no sign of
white pox was apparent at that reef [13]. These experimental and
field observations support the limited virulence of isolate 5, but
virulence of this isolate against one A. palmata fragment is
consistent with the hypothesis that C. abbreviata may function as
an interepizootic reservoir of the APS pathogen or as a vector
when snails that harbor the pathogen feed on host corals.
Acropora palmata inoculated with isolate 3 from APS-affected
corals remained apparently healthy for the entirety of the
experiment, indicating that either this isolate of strain PDR60 is
non-virulent or that the corals on to which it was inoculated were
resistant to APS. Evidence in support of the former conclusion is
Table 3. Bacterial treatments inoculated onto the Acropora palmata fragments in the challenge experiments.
Isolate Strain Source of Collection Location of Collection Date of Collection
1 PDR60 APS-affected Acropora palmata coral Rock Key July 2003
2 PDR60 APS-affected Acropora palmata coral Grecian Rocks July 2003
3 PDR60 APS-affected Acropora palmata coral Grecian Rocks July 2003
4 PDR60 Siderastrea siderea coral Long Key June 2002
5 PDR60 Coralliophila abbreviata snail Sand Key August 2006
6 PDR60 wastewater Key West September 2003
7 PDL100 APS-affected Acropora palmata coral Looe Key May 1999
8 WWI31 wastewater Key West September 2003
Eight isolates of Serratia marcescens representing three pulsed-field gel electrophoresis (PFGE) strains (PDR60, PDL100, and WWI31) were used. The source, location, and
date of collection are included for each treatment.
doi:10.1371/journal.pone.0023468.t003
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each a different genotype and all remained apparently healthy for
the duration of the 26 day study (Table 2). The later conclusion is
supported by the apparent APS resistance of colony 13 (Table 1).
Observations of A. palmata populations suggest that colonies of this
species that are resistant to APS may exist. Prevalence of white pox
disease has declined in recent years coincident with declines in
host coral populations. The most recent reported outbreaks of the
disease occurred in the Florida Keys in 2003 [13] and 2009 (Fig. 1)
and in St. John, US Virgin Islands in 2006 [30]. Lower disease
prevalence may be due to the decimation of susceptible A. palmata
populations during previous white pox epizootics [2,31], other
disease outbreaks [32,33], or may be an indication of reduced
pathogen virulence [34].
Serratia marcescens strain PDL100 exhibited attenuated virulence
in this study, and this strain’s reduced pathogenic effect, combined
with the virulence of strain PDR60 and the wastewater strain
WWI31, raises the question of whether unique strains exist for
other coral pathogens. For instance, coral disease pathogens that
cause white plague (Aurantimonas corallicida) and bacterial-induced
bleaching (Vibrio shiloi) have waned in pathogenicity in recent years
[34]. Limited pathogenicity of A. corallicida, V. shiloi, and S.
marcescens PDL100 may indicate the evolution of host-resistance to
these pathogens [34].
We have shown that distinct strains of Serratia marcescens are
capable of causing disease in Acropora palmata and that strains show
varying levels of apparent virulence with time to disease lesions
ranging from 4 days to 23 days (Table 2). These results may
explain variability in manifestation of APS lesions on A. palmata
colonies in the field including time to infection, rate of tissue loss,
and likelihood of recovery versus whole-colony death. Future
studies will investigate host susceptibility and resistance and will
evaluate genetic variation between S. marcescens isolates and strains
confirmed to be pathogenic and those that do not cause disease or
cause disease at a slower rate. There is a need to define key
differences between S. marcescens strains (PDL100 and PDR60) as
well as among isolates of the same strain (PDR60, e.g., isolates 1–6).
Important differences may exist in their ability to adapt to marine
conditions (i.e., ability to persist and/or grow in seawater) and in
genetic differences leading to increased virulence. S. marcescens vary
widely in their survival in seawater with strain PDL100 surviving
for 15 h or less at 30uC [26] and marine-derived isolates of the
PDR60 pathogen strain persisting for up to 20 days under the
same conditions (KP Sutherland and EK Lipp unpublished data).
Fitness of different S. marcescens strains in seawater may also shed
light on the mode of APS transmission. For example, saltwater
tolerant strains may be more likely to become persistent or even
resident on the reef whereas less halo-tolerant strains may either
die off before reaching the reef or may be responsible for discrete
outbreaks over short time periods. Our data from microcosm
studies suggest that PDL100 (isolated in 1999) follows the latter
pattern [26] and is supported by the fact that this strain has never
been re-isolated from the marine environment [13]. On the other
hand, strain PDR60, which has been recovered from multiple
marine sources [13], is highly persistent in marine waters (KP
Sutherland and EK Lipp unpublished data), suggesting that this
may be an endemic disease strain.
Human culpability in the demise of a threatened species
necessitates an immediate response and supports ongoing
mitigation to improve wastewater treatment in the Florida Keys,
and elsewhere, in order to protect the health and biodiversity of
coral reef ecosystems. Advanced wastewater treatment successfully
removes Serratia marcescens to undetectable levels [13]. However,
most wastewater in the Keys and wider Caribbean is not treated,
but rather is disposed of through in-ground receptacles [35] within
porous limestone substrate that permits leakage from these systems
into near-shore waters [36]. Human fecal contamination of near-
shore and off-shore coral reef environments has been clearly
demonstrated in the Florida Keys [35–38] and elsewhere in the
Caribbean [39] and is associated with waterborne disease in
humans [40]. In response, the state of Florida passed legislation to
improve water quality in the Florida Keys by requiring the
upgrade of all wastewater facilities, including in-ground recepta-
cles, to the best available technology or to advanced wastewater
treatment at an estimated cost of $939 million [41].
Coral reefs are amongst the most critically endangered habitats
on earth. Because population declines of Acropora palmata are
caused, in part, by a human strain of the common fecal enteric
bacterium, Serratia marcescens, our findings address not only
environmental protection, but also the socioeconomic and socio-
ecological determinants of coastal zone protection and the cost of
wastewater treatment infrastructure. This study brings to light a
disease system dynamic, from humans to wildlife, which is the
opposite of the traditional wildlife-to-human disease transmission
model. The passage of pathogens from wildlife to humans is well
documented, but the movement of disease-causing microbes from
humans to marine invertebrates has not been shown [42]. This
‘‘reverse zoonosis’’ is all the more interesting because it involves
the jump of a pathogen from vertebrate to invertebrate and from
terrestrial to marine. Furthermore, disease incidence or severity
may increase with rising temperatures [26,43,44], reinforcing the
importance of near-shore water quality under climate change
scenarios. Given a reliance on tourism by most Caribbean
countries and the widespread lack of consistent wastewater
treatment in the region, the APS disease system is of great
economic interest and public health concern to developing nations
and has particular significance for sustainable development
activities and coastal-zone carrying capacity studies world-wide,
especially under changing climatic conditions.
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